Ledger.Open graph →
SEC Form D · filed October 30, 2020

ONL Therapeutics, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

David Zacks · ANN ARBOR, MIExec · DirectorDavid Esposito · ANN ARBOR, MIExec · DirectorMark Hooper · ANN ARBOR, MIDirectorFelicia David-Visser · ANN ARBOR, MIDirectorChristine Gibbons · Ann Arbor, MIDirectorBenjamin Tsai · Los Angeles, CAExec · DirectorXueying Wang · Austin, TXDirectorOmead K. Ostadan · Redwood City, CAExec · DirectorPatricio Varas · Vancouver, British Columbia, CanadaDirectorJustin M. Quigley · Vancouver, British Columbia, CanadaDirectorJoseph Lemnah · Williston, VTExec · DirectorGunther Van Dender · St. George, UTDirectorAnn P. Hailer · New York, NYDirectorCatherine Badalamente · Detroit, MIDirectorThomas E. Preston · Jamestown, KYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗